Lv11
58 积分 2025-02-23 加入
Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia
2小时前
已完结
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study
6天前
已完结
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia
9天前
已完结
What is the impact of failing to achieve TKI therapy milestones in chronic myeloid leukemia
9天前
已完结
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
9天前
已完结
Deep molecular response in chronic myeloid leukemia
9天前
已完结
Living, not just surviving, with chronic myeloid leukemia – quality of life to the front of the line
9天前
已完结
(Sub)Clonal Wars: IFN Interference Yields the Upper Hand
10天前
已完结
PARP Inhibitors in Breast and Ovarian Cancer
10天前
已关闭
Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy
10天前
已完结
皖公网安备34019202002308
